The report highlights the AACR’s impact on the cancer community during the past year while advancing our mission to prevent and cure all cancers.
Read the AACR Annual Impact ReportCancer is not a single disease, but rather a collection of diseases all characterized by the uncontrolled proliferation of cells.
Learn MoreJoin us on June 24 at 12:30 p.m. ET for this free virtual event on the AACR Cancer Disparities Progress Report 2024, highlighting advances against cancer disparities and recommending actions to achieve health equity.
Learn More and RegisterAn estimated 22,370 people in the U.S. are expected to be diagnosed with esophageal cancer this year. Get more information about prevention, screening, and treatments for esophageal cancer.
Learn MoreDisparities in the Burden of Preventable Cancer Risk Factors: Decades of systemic inequities and social injustices have led to a disproportionately higher burden of cancer risk factors among U.S. racial and ethnic minority groups.
Read the ReportThe Week in Cancer News: A roundup of significant cancer research news from the past week, selected by the staff of Cancer Today magazine.
Learn MoreWhether honoring a special person or a special day, a donation to the American Association for Cancer Research has a lasting impact.
Donate NowSession recordings are available for viewing to registered attendees through July 10. Registration remains open for the on-demand virtual meeting.
The AACR Cancer Disparities Progress Report 2024 outlines the complex interplay of factors that drive and perpetuate cancer health disparities and calls for a collaborative approach to achieve health equity.
Learn MoreThe AACR and its more than 58,000 members worldwide are advancing a scientifically bold agenda against the collection of diseases we call cancer.
Learn MoreDr. Winn, chair of the AACR Cancer Disparities Progress Report 2024 steering committee, discusses the many factors that drive and perpetuate cancer health disparities.
Learn Morepercent decrease of the overall age-adjusted cancer death rate in the U.S. from 1991 to 2020
Learn Moretherapeutics were approved for new or expanded uses by the FDA from Aug. 1, 2022, to July 31, 2023
Learn Moremillion cancer survivors in the U.S. are living with, through, and beyond their disease thanks to research
Learn More